Literature DB >> 16087116

Anticoagulation in atrial fibrillation and flutter.

M F Scholten1, A S Thornton, J M Mekel, P J Koudstaal, L J Jordaens.   

Abstract

Atrial fibrillation and atrial flutter are important risk factors for stroke. Based on a literature search, pathogenesis of thromboembolism, risk assessment in patients, efficacy of anticoagulation therapy and its alternatives are discussed. Special emphasis is put on issues like paroxysmal atrial fibrillation, atrial flutter and anticoagulation surrounding catheter ablation and cardioversion. A strategy for anticoagulation around the time of pulmonary vein ablation is suggested.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087116     DOI: 10.1016/j.eupc.2005.05.012

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  Incidence and predictive factors of atrial fibrillation after ablation of typical atrial flutter.

Authors:  Valérie Laurent; Laurent Fauchier; Bertrand Pierre; Caroline Grimard; Dominique Babuty
Journal:  J Interv Card Electrophysiol       Date:  2008-11-04       Impact factor: 1.900

2.  Knowledge, attitude, and behavior in patients with atrial fibrillation undergoing radiofrequency catheter ablation.

Authors:  Wenhua Xu; Guozhen Sun; Zheng Lin; Minglong Chen; Bing Yang; Hongwu Chen; Kejiang Cao
Journal:  J Interv Card Electrophysiol       Date:  2010-06-16       Impact factor: 1.900

3.  Diagnosis and Management of 1:1 Atrial Flutter in the Setting of Aortic Valve Endocarditis and Embolic Stroke.

Authors:  Bisrat Nigussie; Fuad I Abaleka; Maham Suhail; Esmael Yimer; Francesco Rotatori
Journal:  Cureus       Date:  2020-06-21

4.  Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study.

Authors:  Yung-Lung Chen; Yu-Sheng Lin; Hui-Ting Wang; Wen-Hao Liu; Huang-Chung Chen; Mien-Cheng Chen
Journal:  Europace       Date:  2019-02-01       Impact factor: 5.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.